Pardes to Start Trial of Covid-19 Antiviral Pill
Investing.com — Pardes Biosciences Inc (NASDAQ:) expects to begin a mid-to-late stage trial of its new Covid-19 antiviral capsule by mid-year, ...
Tag: Pardes
Investing.com — Pardes Biosciences Inc (NASDAQ:) expects to begin a mid-to-late stage trial of its new Covid-19 antiviral capsule by mid-year, ...